How stress-related noradrenaline receptors affect the brain's memory and control center
Prefrontal impairment with stress- NE receptor subtype mechanisms.
This work looks at whether specific noradrenaline (norepinephrine) receptor types change prefrontal cortex function in ways that matter for people with stress-related problems like PTSD.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11283919 on NIH RePORTER |
What this research studies
From a patient perspective, researchers are trying to understand why stress weakens the brain area that controls working memory and self-control. They will label and image specific adrenergic receptor subtypes on different brain cells in rhesus monkeys and use high-resolution microscopy to see exactly where those receptors sit. While monkeys perform working memory tasks, scientists will record single-neuron activity and selectively stimulate receptor subtypes to see how firing and signaling change. The combined mapping and functional recordings aim to reveal which receptor targets protect or harm prefrontal function under stress.
Who could benefit from this research
Good fit: People with PTSD, severe stress-related concentration or working-memory problems, or anxiety disorders that impair cognitive control would be the most likely to benefit from future treatments informed by this work.
Not a fit: Patients whose conditions are unrelated to stress-driven noradrenergic dysfunction (for example advanced primary neurodegenerative diseases) or who cannot take adrenergic-targeting medications may not receive direct benefit.
Why it matters
Potential benefit: If successful, this could point to more precise drug targets that better protect thinking, memory, and self-control in PTSD and other stress-related disorders.
How similar studies have performed: Drugs that block broad α1- or β-adrenergic receptors (like prazosin or propranolol) have shown mixed results clinically, and this project is novel in testing individual receptor subtypes in primate prefrontal cortex.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Arnsten, Amy F.t. — Yale University
- Study coordinator: Arnsten, Amy F.t.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.